Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...

PreEvnt isaac device uses breath analysis to monitor glucose levels without needles, drawing attention at CES 2026 as a ...

Fully automated, ultra-high-volume line providing sub-second cycle time, medical-grade precision, and scalable capacity ...

The study explains the mechanism behind up to 100× sensitivity amplification in glucose sensorsThe article was published in Biosensors and ...

By Karen Roman GlucoTrack, Inc. (Nasdaq: GCTK) said the U.S. Patent and Trademark Office issued three patents for its ...

Apple Watch now supports glucose monitoring via CGMs like Dexcom G7, while Apple continues long-term work on non-invasive blood sugar tracking.

Letitia explains how a small medical device, designed to help manage the illness, is now blamed for sending hundreds of ...

Investing.com -- Glucotrack Inc. (NASDAQ:GCTK) stock surged 60% Thursday after the company announced that the U.S. Patent and Trademark Office (USPTO) has approved three patents for its continuous ...

The monitors were giving incorrect, low readings.

Health conditions often come with assumptions that aren’t always accurate or fair. So what would you do if someone noticed your medical device and assumed you had one condition, when in reality you ...

Hooked to those 'what will this food item do to my blood sugar level?' videos on social media? They can be addictive to watch, but they don't always give you the full picture of what's healthy.

An international research team led by the Medical University of Vienna has shown that continuous glucose monitoring (CGM) in ...